Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Apply
OPGx-BEST1
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step